This financial aid form is the key to non-federal aid at some colleges Greg Daugherty has worked 25+ years as an editor and writer for major publications and websites. He is also the author of two ...
IT: Welcome to Derry, starring Bill Skarsgård and inspired by Stephen King’s classic novel, premieres on streaming and cable on Sunday. Forbes‘IT: Welcome To Derry’ Rotten Tomatoes Reviews: Does ...
Replimune Group announced that the U.S. Food and Drug Administration has accepted the resubmission of its Biologics License Application for RP1 in combination with nivolumab, targeting advanced ...
Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...
Despite the relentless insistence of tech’s grifters, AI is not industrially inevitable – or even sustainable. Which is why it is time to push back Bad news, baby. The New Yorker reports the rapid ...
Replimune Group’s REPL share price tumbled 54.2% over the past three months. The massive setback was observed after the FDA issued a complete response letter (CRL) in July, against the biologics ...
The last time I spoke about Replimune (REPL) it was with respect to a Seeking Alpha article entitled "Replimune: Scope Goes Beyond That of RP1 Oncolytic Targeting For Melanoma." With respect to this ...
The fate of a once-promising cancer treatment now looks uncertain at best. The meeting was conducted with U.S. Food and Drug Administration (FDA) officials, and it took place on Tuesday. The subject ...
On July 22, 2025, the U.S. Food and Drug Administration issued a Complete Response Letter for RP1, delaying potential commercialization and revenue. Research and development expenses increased 34.6% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback